Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Emergent COVID-19 Vaccine Plant’s Quality Issues Draw Unusual Spotlight From US FDA Topsiders

Apr 22 2021

• By Bowman Cox

Emergent BioSolutions — some improvising was going on in overcrowded plant • Source: Alamy

Related Content

Industry Worries FDA Will See Drug GMP Violations Captured By Security Cameras

Sep 10 2017

Emergent Suspends COVID-19 Vaccine API Manufacturing As US FDA Inspects Bayview Plant

Apr 20 2021

Related Companies

Emergent BioSolutions, Inc.

Additional Topics

United States Coronavirus COVID-19 Vaccines Quality Compliance Manufacturing Enforcement BioPharmaceutical

More from Vaccines

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window